Unknown

Dataset Information

0

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis.


ABSTRACT: The present study aimed to investigate the incidence of hepatocellular carcinoma (HCC) and factors related to HCC occurrence after direct-acting antiviral (DAA) treatment in the Fukushima Liver Academic Group (FLAG). We conducted a multicenter retrospective cohort study of 1068 patients without cirrhosis (NC) or with compensated liver cirrhosis (LC) who achieved a sustained virologic response (SVR). First, we compared the cumulative HCC incidence and survival rates in NC (n = 880) and LC (n = 188) patients without a history of HCC treatment. Second, we performed multivariate analysis of factors related to HCC occurrence after DAA treatment. Overall, the average age was 65 years, and the male/female ratio was 511/557. Thirty-nine (4%) patients developed HCC. The cumulative 4-year HCC incidence and survival rates were 3.0% and 99.8% in NC patients and 11.5% and 98.5% in LC patients, respectively. The independent factors affecting HCC occurrence identified by multivariate analysis were the serum albumin (ALB) level before SVR for NC patients and the ALBI score, platelet count, and diabetes before SVR for LC patients. The factors related to HCC occurrence differed between NC and LC patients. Careful surveillance of post-SVR patients with these risk factors is needed.

SUBMITTER: Abe K 

PROVIDER: S-EPMC7721183 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis.

Abe Kazumichi K   Wakabayashi Hiroto H   Nakayama Haruo H   Suzuki Tomohiro T   Kuroda Masahito M   Yoshida Naoe N   Tojo Jun J   Kogure Atsuko A   Rai Tsuyoshi T   Saito Hironobu H   Mukai Shinji S   Fujita Masashi M   Hayashi Manabu M   Takahashi Atsushi A   Ohira Hiromasa H  

PloS one 20201207 12


The present study aimed to investigate the incidence of hepatocellular carcinoma (HCC) and factors related to HCC occurrence after direct-acting antiviral (DAA) treatment in the Fukushima Liver Academic Group (FLAG). We conducted a multicenter retrospective cohort study of 1068 patients without cirrhosis (NC) or with compensated liver cirrhosis (LC) who achieved a sustained virologic response (SVR). First, we compared the cumulative HCC incidence and survival rates in NC (n = 880) and LC (n = 18  ...[more]

Similar Datasets

| S-EPMC2898187 | biostudies-literature
| S-EPMC5897179 | biostudies-literature
| S-EPMC6815714 | biostudies-literature
| S-EPMC6135856 | biostudies-other
| S-EPMC5837901 | biostudies-literature
| S-EPMC6283079 | biostudies-other
| S-EPMC5108417 | biostudies-literature
| S-EPMC8742091 | biostudies-literature
| S-EPMC2653326 | biostudies-literature
| S-DIXA-D-1137 | biostudies-other